Schisandrin®

INDICATIONS FOR USE

Dietary supplement to the diet – an additional source of lignans. The components of “Schizandrin” can help maintain the functional state of the liver, general well-being, normalize metabolic processes and protect cells from oxidative stress.

COMPOSITION

Filler whey – 40.0%, filler potato starch – 20.0%, filler lactose – 19.0%, schisandrin – 10.0% (25.0 mg), filler MCC – 8.0%, anti-caking agent calcium stearate – 2.0%, anti-caking agent silicon dioxide – 1.0%.

APPLICATION

Adults: 1–2 tablets 3 times a day after meals. Do not exceed the recommended daily amount. The recommended period of use is from 3 to 6 months. If necessary, the course can be repeated. Before starting use, it is recommended to consult a specialist.

CONTRAINDICATIONS

Not recommended for individuals with individual sensitivity to any component of the product, during pregnancy and breastfeeding, and for children under 18 years of age. If you have functional disorders of the digestive organs or chronic conditions associated with the gastrointestinal tract, it is advisable to consult a specialist before consumption.

ENERGY VALUE KCAL / 100 G

144,4 kcal

NUTRITIONAL VALUE OF 100 G OF THE PRODUCT

Proteins – 1,0 g; fats – 0 g; carbohydrates – 35,1 g

HOW SUPPLIED

10 tablets per blister, 3 blisters per package.

SHELF LIFE

24 months

ADDITIONAL INFORMATION

Polycystic ovary syndrome: an approach to the correction of metabolic disorders – L.V. Kalugina, MD. Ph.D., leading researcher of the department of endocrine gynecology of the State University “Institute of Pediatrics, Obstetrics and Gynecology named after Acad. OHM. Lukyanova National Academy of Sciences of Ukraine”, Kyiv // “Reproductive endocrinology”, № 2 (52) / May 2020, p. 54-60

Type 2 diabetes and non-alcoholic fatty liver disease: new possibilities of therapeutic correction – Dorofeev A.E. (National Medical Academy of Postgraduate Education named P.L. Shupyk, Kyiv, Ukraine), Rudenko N.N. (National Medical University named A.A. Bogomolts, Kyiv, Ukraine), Tkach S.M. (Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kyiv, Ukraine), Shvets O.V. (VGO “Association of Dietitians of Ukraine”, Kyiv, Ukraine), Cheverda T.L. (National Medical Academy of Postgraduate Education named P.L. Shupyk, Kyiv, Ukraine)// “Gastroenterology”, Volume 53, № 4, 2019, p. 18-25

A Look on the Liver Fibrosis in the Light of Understanding Modern Mechanisms of its Development – Kolesnikova O. V. SE “L. T. Mala National Institute of Therapy of the NAMS of Ukraine”, Kharkiv, Ukraine// “Gastroenterology”, Volume 53, Issue 2, 2019, p.p. 67-76

New Possibilities for Nonalcoholic Steatohepatitis Treatment – Fadieienko G. D., Kolesnikova O. V., Solomentseva T. A., SE “L. T. Mala National Institute of Therapy of the NAMS of Ukraine”, Kharkiv, Ukraine// Volume 52, Issue 3, 2018, p.p. 16-21